Skip to main content

Mitomycin C Offers Alternative, but Cisplatin-Based Chemoradiation Remains Standard in Head and Neck Cancer

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Mitomycin C Offers Alternative, but Cisplatin-Based Chemoradiation Remains Standard in Head and Neck Cancer

User login

Username

Password

Reset your password

Type	Lead	score